Organovo Holdings Return on Equity

Organovo Holdings (ONVO) currently reports a ROE of 525.92%. That is above the Healthcare sector average of 22.01%. Use the charts on this page to explore Organovo Holdings's ROE history and peer comparisons.

Organovo Holdings's ROE of 525.92% is higher than the Healthcare sector average of 22.01%. That is roughly 2289.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Organovo Holdings's current 525.92% should be judged against Healthcare norms (sector average: 22.01%) and against ONVO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 525.92%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.01%. From there, open related valuation or income-statement pages for Organovo Holdings, and consider following ONVO for alerts when major investors trade the stock.

Organovo Holdings is classified in the Healthcare sector. On ROE, it currently shows 525.92% versus a sector average near 22.01%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ONVO with unrelated industries.